XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2020
Summary of Stock option and restricted stock activity

A summary of stock option and restricted stock activity under the 2008 Plan and Inducement Grant during the nine months ended September 30, 2020 and 2019 is presented below:

(in thousands)

Options

Inducement Grants

RSAs

Outstanding at December 31, 2018

 

759

117

Granted

 

160

122

Options Exercised/RSAs Vested

 

(117)

(42)

 (1)

Forfeited

 

(24)

(3)

Expired

 

(1)

Outstanding at September 30, 2019

 

777

194

Outstanding at December 31, 2019

 

757

192

Granted

 

42

180

305

Options Exercised/RSAs Vested

 

(8)

(128)

 (2)

Forfeited

 

(44)

(17)

Expired

 

Outstanding at September 30, 2020

 

747

180

352

(1)Includes 15 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $1.0 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
(2)Includes 43 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $1.5 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
Employee Stock Purchase Plan 2016 [Member]  
Summary of allocated expense

(in thousands)

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2020

    

2019

    

2020

    

2019

    

Cost of sales

$

3

$

4

$

14

$

10

Research and development

 

6

 

7

 

25

 

16

Selling, general, and administrative

 

23

 

19

 

79

 

64

$

32

$

30

$

118

$

90

Stock Incentive Plan 2008 [Member]  
Summary of allocated expense

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands)

    

2020

    

2019

    

2020

    

2019

    

Cost of sales

$

34

$

26

$

93

$

75

Research and development

 

117

 

213

 

450

 

545

Selling, general, and administrative

 

2,200

 

2,201

 

9,882

 

6,063

$

2,351

$

2,440

$

10,425

$

6,683